Overview

Centocor Microarray Study of Patients

Status:
Completed

Trial end date:
2010-08-01

Target enrollment:

Participant gender:

Summary

Specific Aim 1. To determine the transcriptome of peripheral blood mononuclear cells isolated monocytes and target tissues in IMIDs. Specific Aim 2. To analyze the change in gene expression profiles in patients with Crohn's disease, psoriatic and rheumatoid arthritis before and after infliximab therapy.

Phase:

Phase 4

Details

Lead Sponsor:

University of Rochester

Collaborator:

Centocor, Inc.

Treatments:

Infliximab